Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)

RAPID (Evaluating the Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes in Real World Practice)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00526552

Acronym

RAPID

Enrollment

5000

Registered

2007-09-10

Start date

2007-06-30

Completion date

2007-12-31

Last updated

2010-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Dyslipidemia

Keywords

dyslipidemia, rosuvastatin, diabetes, cholesterol, Naturalistic, Observational

Brief summary

To evaluate the efficacy of rosuvastatin in Korean dyslipidemia patients with diabetes

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Hyperlipidemia patients who are prescribed with rosuvastatin 10mg, based on clinical grounds and fulfil the following criteria 1. Over 18 years of age 2. Diagnosed with DM based on fasting or post-load glucose data and/or clinical assessment by the clinician

Exclusion criteria

1. Patients already taking other hyperlipidemic agents 2. Patients who do not fulfil the indication criteria for statin therapy 3. Patients who do not have baseline and/or follow-up lipid data to verify the efficacy data

Countries

South Korea

Outcome results